22 May 2013
Keywords: dosing, begins, ph, ib, trial, genaera, trodusquemine
Article | 08 December 2008
US drug developer Genaera has started dosing subjects in study MSI-1436C-102, a multiple ascending-dose Phase Ib trial of
trodusquemine ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 December 2008
21 May 2013
© 2013 thepharmaletter.com